Search Results - "Gruys, M E"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L by Lee, J.-K., Seki, N., Sayers, T.J., Subleski, J., Gruys, E.M., Murphy, W.J., Wiltrout, R.H.

    Published in Cellular Immunology (01-06-2005)
    “…CD40, a member of the TNF receptor superfamily, is expressed on B cells, dendritic cells, and some tumor cells, including melanoma and bladder carcinoma. In…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2) by Park, J W, Gruys, M E, McCormick, K, Lee, J K, Subleski, J, Wigginton, J M, Fenton, R G, Wang, J M, Wiltrout, R H

    Published in The Journal of immunology (1950) (15-03-2001)
    “…The IFN-gamma-inducible proteins monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2) can contribute to IL-12-induced antiangiogenic…”
    Get full text
    Journal Article
  4. 4

    Flavone acetic acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes by FUTAMI, H, EADER, L. A, KOMSCHLIES, K. L, BULL, R, GRUYS, M. E, ORTALDO, J. R, YOUNG, H. A, WILTROUT, R. H

    Published in Cancer research (Chicago, Ill.) (15-12-1991)
    “…Flavone-8-acetic acid (FAA) is a flavonoid drug that augments mouse natural killer activity, induces cytokine gene expression, and synergizes with recombinant…”
    Get full text
    Journal Article
  5. 5

    Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow by Wiltrout, RH, Pilaro, AM, Gruys, ME, Talmadge, JE, Longo, DL, Ortaldo, JR, Reynolds, CW

    Published in The Journal of immunology (1950) (01-07-1989)
    “…A variety of biologic response modifiers (BRM) can potently augment NK activity in nonlymphoid organs. By using the liver as a model organ, we have shown that…”
    Get full text
    Journal Article
  6. 6

    Induction of transplantable mouse renal cell cancers by streptozotocin : In vivo growth, metastases, and angiogenic phenotype by GRUYS, M. Eilene, BACK, Timothy C, WILTROUT, Robert H, SUBLESKI, Jeff, WILTROUT, Theresa A, LEE, Jong-Keuk, SCHMIDT, Laura, WATANABE, Morihiro, STANYON, Roscoe, WARD, Jerrold M, WIGGINTON, Jon M

    Published in Cancer research (Chicago, Ill.) (15-08-2001)
    “…Interleukin-2-based regimens of biological therapy have shown some clinical promise for the treatment of kidney cancer in humans, although the mechanisms…”
    Get full text
    Journal Article
  7. 7

    Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases by Komschlies, KL, Gregorio, TA, Gruys, ME, Back, TC, Faltynek, CR, Wiltrout, RH

    Published in The Journal of immunology (1950) (15-06-1994)
    “…These studies investigate the effects of exogenously administered recombinant human IL-7 (rhIL-7) on mouse leukocyte subsets in vivo in normal and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    In vivo distribution and cytokine gene expression by enriched mouse LAK effector cells by FUTAMI, H, PILARO, A. M, GRUYS, M. E, BACK, T. C, YOUNG, H. A, WILTROUT, R. H

    Published in Biotherapy (Dordrecht) (1991)
    “…Lymphokine activated killer (LAK) cells administered in combination with interleukin 2 (IL2) can mediate antitumor activity in tumor-bearing mice and advanced…”
    Get full text
    Journal Article
  10. 10

    Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1 : protection from hematological and nonhematological toxicities by DAMIA, G, KOMSCHLIES, K. L, FUTAMI, H, BACK, T, EILENE GRUYS, M, LONGO, D. L, KELLER, J. R, RUSCETTI, F. W, WILTROUT, R. H

    Published in Cancer research (Chicago, Ill.) (01-08-1992)
    “…Previous studies have demonstrated that interleukin 1 (IL-1) can protect most mice from the acute lethal toxicity mediated by high doses of radiation and/or…”
    Get full text
    Journal Article